Respiratory

ResMed’s myAir Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea

ResMed recently announced new European research from Price Waterhouse Coopers (PwC), revealing that patients with sleep apnea who use ResMed’s myAir have greater adherence to CPAP (continuous positive airway pressure) therapy than those who don’t.

Read More

Philips Respironics, ResMed Lead Multi-Billion Dollar Anesthesia, Respiratory and Sleep Management Device Market

The anesthesia, respiratory and sleep management market in the U.S. is expected to increase to reach nearly $5.5 billion by 2023; the market is largely influenced by insurance policies, especially when it comes to durable devices governed under the durable manufacturer equipment (DME) realm.

Read More

Growth in the U.S. Oxygen Therapy Market

  The market for portable oxygen concentrators continues to grow at double digit rates, with the share of ambulatory oxygen therapy patients on portable oxygen concentrators increasing steadily. The overall oxygen therapy market is broken into 6 types of devices:

Read More

AIMS Implementation to Drive U.S. Anesthesia, Respiratory and Sleep-Management Device Market

The U.S. anesthesia, respiratory and sleep-management device market will reach approximately $4 billion by 2017. Market growth will be driven by high sales of anesthesia information management systems (AIMS), which work to automate data collection in the anesthesia department, streamline

Read More
iData Research - provides expertly driven global market research on the medical device industry.
iData Research Website

Join our community of 30,000 subscribers

Sign-up to receive medical market news
* indicates required field